Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Estrogen receptor (ER)-negative cancers have a poor prognosis, and few targeted therapies are available for their treatment. Our previous analyses have identified potential kinase targets critical for the growth of ER-negative, progesterone receptor (PR)-negative and HER2-negative, or “triple-negati...

Full description

Saved in:
Bibliographic Details
Published in:Breast Cancer Res Treat
Main Authors: Mazumdar, Abhijit, Poage, Graham M., Shepherd, Jonathan, Tsimelzon, Anna, Hartman, Zachary C., Den Hollander, Petra, Hill, Jamal, Zhang, Yun, Chang, Jenny, Hilsenbeck, Susan G., Fuqua, Suzanne, Kent Osborne, C., Mills, Gordon B., Brown, Powel H.
Format: Artigo
Language:Inglês
Published: Springer US 2016
Subjects:
Preclinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963453/
https://ncbi.nlm.nih.gov/pubmed/27393618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3892-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items